Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Charles River Laboratories
 More »

  • GEN | Biolinks
    Life Sciences Association Bio-Rad Laboratories BioAlberta BioAlps (Lake Geneva Life ... Cevec Pharmaceuticals ChanTest Charles River Labs Chile Biotech Chinese Bioscience ...
  • Demand, Currency Lower Charles River Results
    Charles River Laboratories is blaming flat demand by smaller biopharmas, foreign currency fluctuations, and the addition last year of a 53rd week for fourth quarter dips in profits ...
    2-14-2013
  • J.P. Morgan Buzz: January 8, 2013 Update
    Here are some of his highlights from Day 2 of the meeting: James Foster, long-time president and CEO of Charles River Laboratories, reported that his company's early stage drug ...
    1-9-2013
  • SeraCare Sheds Biorepository Assets, Focuses on IVD
    on marketing, strategy, and corporate development activities, after holding senior positions with Charles River Laboratories, QIAGEN, and Invitrogen (now Life Technologies). ...
    1-4-2013
  • AZ Looks to Charles River Labs for In Vivo Biology
    AstraZeneca said today it will create a combined research platform with Charles River Laboratories by outsourcing to the contract research organization its regulated safety ...
    10-17-2012
  • New PCR-Based Health Testing Is Changing the Game
    It contains individual PCR assays in a high-density format. [Charles River] Wearing a long ... Instead of requiring entire sentinel animals, diagnostic laboratories using PCR-based ...
    9-11-2012
  • GEN Reports on Recent Progress in Alzheimer's Research
    AstraZeneca, Roche, TransTech Pharma, Astex Pharmaceuticals, Memory Pharmaceuticals, Sanofi-Aventis, Eli Lilly, GE Healthcare Life Sciences, and Charles River Laboratories.
    9-10-2012
  • Charles River Buys Accugenix for $17M
    Charles River Laboratories acquired cGMP contract microbial identification and typing firm Accugenix for $17 million in cash. Charles River says the buyout will strengthen its own ...
    8-30-2012
  • Virus Preparation for Filter Validation
    ... Aspects of the methods are patent-pending and are designed to be readily transferable to our partner Charles River Laboratories. Virus stocks produced are high titer, low protein, ...
    8-1-2012
  • CRO Capabilities Expand to Suit Client Needs
    ... One needs to be careful regarding the CRO acronym, as the definition depends on where the company focuses its service offering. Charles River Laboratories and MPI Research are ...
    5-15-2012
  • EMD Millipore, Charles River Laboratories Ally for Improved Viral...
    EMD Millipore and Charles River Laboratories have inked an agreement to enhance viral clearance services. Under terms of the deal Charles River gains an exclusive license for EMD ...
    2-27-2012
  • ShangPharma Snaps Up Charles River Facility in Shanghai
    ShangPharma is buying Charles River Laboratories' Shanghai research facility and related assets to grow its in vivo pharmacology services.The deal was reached through ShangPharma's ...
    10-24-2011
  • Advertorial: Scottish Development International
    Scotland offers a vibrant commercial supply chain working alongside global life science corporations such as EMD Millipore, Charles River Laboratories, and Life Technologies. ...
    10-1-2011
  • CROs Adapt to Meet Changing Paradigms
    ... Since its inception more than 60 years ago, Charles River Laboratories has seen the entire gamut of partnership agreements with pharma. In his talk, David Collins, senior manager, ...
    5-15-2011
  • Charles River to Distribute Pfizer Research Models
    Charles River Laboratories inked an agreement with Pfizer to market and distribute to researchers worldwide precompetitive, transgenic research models. The Pfizer-developed models ...
    3-3-2011

  • Journal Articles

  • Design, Synthesis, and Evaluation of Radiolabeled Integrin α...
    Thomas D. Harris, Shirley Kalogeropoulos, Tiffany Nguyen, Shuang Liu, Judit Bartis, Charles Ellars, Scott Edwards, David Onthank, Paula Silva, Padmaja Yalamanchili, Simon Robinson, Joel Lazewatsky, John Barrett, Jeffrey Bozarth
    Cancer Biotherapy and Radiopharmaceuticals
    TA138 forms stable complexes with 111In and 90Y in > 95% RCP. 111In-TA138 demonstrates high tumor uptake in the c-neu Oncomouse® (Charles River Laboratories [Charles River, ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll